SAB Biotherapeutics, Inc. (SABS)
NCM – Real vaqt narxi. Valyuta: USD
3.78
+0.02 (0.53%)
Bozor ochiq: Aug 12, 2026, 1:12 PM EDT
3.77
+0.01 (0.27%)
Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NCM – Real vaqt narxi. Valyuta: USD
3.78
+0.02 (0.53%)
Bozor ochiq: Aug 12, 2026, 1:12 PM EDT
3.77
+0.01 (0.27%)
Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT
No Data
Ushbu aksiya uchun yangiliklar yo'q.
Kompaniyaning naqd pul zahiralari $8.3M umumiy qarzdan $5.1M sezilarli darajada ko'p bo'lib, kuchli moliyaviy moslashuvchanlikni ta'minlaydi
Jami joriy aktivlar $107.9M jami joriy majburiyatlardan $11.7M ko'p bo'lib, ajoyib likvidlikni ta'kidlaydi
Qarz/kapital nisbati (0.0) tarmoq o'rtachasidan (0.3) sezilarli past bo'lib, ehtiyotkor moliyaviy boshqaruvni namoyish etadi
Foiz qoplash koeffitsiyenti (-377.0x) xavfli darajada past bo'lib, qarzni qaytarish xavflarini ko'rsatadi
Salbiy erkin pul oqimi -$11.4M kompaniyaning qayta investitsiya qilish yoki qarzni to'lash qobiliyatini cheklaydi
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 9.22 | 6.05 | 10 | |
| Tezkor likvidlik nisbati | 9.22 | 5.63 | 10 | |
| Qarz/Kapital nisbati | 0.02 | 0.30 | 9.0 | |
| Qarz/Aktivlar nisbati | 0.02 | 1.04 | 9.0 | |
| Foiz to‘lov qoplami | -377.05 | -16.91 | 1.0 | |
| O‘rtacha ball | 7.8 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | 24M | 2M | 1M | N/A | N/A |
| Yalpi foyda | 21M | -2M | -3M | -3M | -3M |
| Operatsion daromad | -29M | -38M | -43M | -49M | -72M |
| Sof foyda | -19M | -42M | -34M | 4M | -39M |
| EBITDA | -26M | -34M | -38M | -46M | -69M |
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | N/A | -29.69 | 1.0 |
| Keyingi chorak | N/A | 1.61 | 2.0 |
| Joriy yil | N/A | -43.78 | 1.0 |
| Keyingi yil | N/A | 27.3 | 5.5 |
| O‘rtacha ball | 2.4 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | 999 | -19.19 | 20 | 25.09 | 7.5 |
| Yil/Yil | 999 | -122.36 | 74.31 | -59.77 | 5.5 |
| 3 yil o‘rtacha | -77.17 | 2.18 | 17.57 | -22.51 | 3.5 |
| 5 yil o‘rtacha | 141.35 | -37.59 | 21.11 | -96.41 | 5.5 |
| O‘rtacha ball | 5.5 | ||||
Insufficient positive free cash flow for DCF analysis
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |